# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-389643
Filing Date
2014-10-30
Accepted
2014-10-30 16:12:20
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | d778073d10q.htm | 10-Q | 557420
2 | EX-31.1 | d778073dex311.htm | EX-31.1 | 5910
3 | EX-31.2 | d778073dex312.htm | EX-31.2 | 5893
4 | EX-32.1 | d778073dex321.htm | EX-32.1 | 2448
5 | EX-32.2 | d778073dex322.htm | EX-32.2 | 2417
| Complete submission text file | 0001193125-14-389643.txt |  | 4141136

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE DOCUMENT | ogxi-20140930.xml | EX-101.INS | 517348
7 | XBRL TAXONOMY EXTENSION SCHEMA | ogxi-20140930.xsd | EX-101.SCH | 39567
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | ogxi-20140930_cal.xml | EX-101.CAL | 52954
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | ogxi-20140930_def.xml | EX-101.DEF | 164607
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | ogxi-20140930_lab.xml | EX-101.LAB | 338252
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | ogxi-20140930_pre.xml | EX-101.PRE | 251191

Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 141183378
SIC: 2835 In Vitro & In Vivo Diagnostic Substances